CA Patent

CA2604943C — Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same

Assigned to Tolmar Inc · Expires 2013-09-17 · 13y expired

What this patent protects

A drug delivery system for oral administration of hydrophobic drugs with enhanced and extended absorption and improved pharmacokinetics is provided. In one embodiment, formulations comprising testosterone and testosterone esters, e.g., testosterone palmitate, are disclosed. Metho…

USPTO Abstract

A drug delivery system for oral administration of hydrophobic drugs with enhanced and extended absorption and improved pharmacokinetics is provided. In one embodiment, formulations comprising testosterone and testosterone esters, e.g., testosterone palmitate, are disclosed. Methods of treating a hormone deficiency or effecting male contraception with the inventive formulations are also provided.

Drugs covered by this patent

Patent Metadata

Patent number
CA2604943C
Jurisdiction
CA
Classification
—
Expires
2013-09-17
Drug substance claim
No
Drug product claim
No
Assignee
Tolmar Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.